Meet Top Level Pharma Executives |
|
Leadership Session #3
Title: Matching Canadian Technology with Big Pharma’s need for Innovative New Drugs
Discover why Canada is the fourth largest biocluster in the world. Local British Columbia biotech CEO, Ali Tehrani of Zymeworks will discuss their partnership with large pharmaceutical company, Merck. These two companies recently came together through a mutual desire to develop new biologics with improved therapeutic properties. Christian Hordo from Genentech and Simon Pimstone of Xenon join this panel discussion chaired by the President of LifeSciences British Columbia, Don Enns. Read more...
|
Dr. Steven Xanthoudakis, Director, Licensing and External Research - Canada, Merck & Co Inc.

|
Dr. Ali Tehrani, President and Chief Executive Officer, Zymeworks Inc.
|
|
Mr. Christian Hordo, Manager, Business Development, Genentech, Inc.

|
Dr. Simon Pimstone, President & Chief Executive Officer, Xenon
|
|
 |
Building Crossroads, Partnerships & Making Deals |
BioPartnering North America (BPN) focuses on the Pacific Rim because this is where a lot of life science business will be taking place in the years to come. We plan to build on close ties with industry leaders in the Pacific Rim to create a unique opportunity for the U.S., Canada, and Europe to meet leading life science companies from Asia.
BPN is expanding, to meet new needs, which reflect the changing world realities. It represents a cutting-edge solution to the major problem faced by busy executives: “who should I meet with today?” Business opportunities and strategic partnerships exist for pharma, investors, and emerging biotech companies – this is what BPN helps life science companies do. BPN is a focused event for serious dealmakers!
LEARN MORE
|
Who Will You Meet?
View all 2012 Participants